Armstrong Pharmaceuticals Inc. / Amphastar Pharmaceuticals Inc. / SUSSMAN / Latham & Watkins / LLP / Latham Watkins LLP / Watkins John Manthei / Supervisory Industry / Allergy & Asthma Network / /
Country
United States / /
Facility
FDA facility / /
IndustryTerm
law / /
MedicalCondition
Pulmonary / MS / Asthma / Government Affairs Allergy / /
Organization
office of Executive Programs / Food and Drug Administration Center for Drug Evaluation and Research / FOOD AND DRUG ADMINISTRATION / office of Nonprescription Drug Products / Stratospheric Protection Division / NEAL R. GROSS COURT / office of Atmospheric Programs / office of Regulatory Policy / office of Policy & Legislation / CENTER FOR DRUG EVALUATION AND RESEARCH / CDER's office of Kirsten Cappel / Environmental Protection Agency / /
Person
CLARK NARDINELLI / Closing Remarks Charles Ganley / Epinephrine Charles Ganley / NANCY SANDER / EPA BADRUL CHOWDHURY / John Manthei / CHARLES GANLEY / M. Sussman / WEITIAN TAN / ROSE CUNNINGHAM / Sandra J. Fusco-Walker / MARTHA NGUYEN / Allergy Drug / KIRSTEN CAPPEL / NEAL R. GROSS / / /
Position
Economist / Counsel / Director of the Division / Director of Scientific Affairs / President / speaker / Director / Scientific Affairs / Environmental Protection Specialist / Director 18 Government / director of the economic staff / Director / Government Affairs / Director / Division of Pulmonary & Allergy Drug Products / Director / Commissioner / counsel in MS. CAPPEL / Senior Director / Scientific Affairs / Director / Government Affairs Allergy and Asthma Network Mothers / Regulatory Counsel / /
Microsoft Word - 1205fda.doc